CN Patent
CN111484479B — 氮杂环化合物、包含其的药物组合物及其制备方法和用途
Assigned to Sichuan Kelun Biotech Biopharmaceutical Co Ltd · Expires 2023-06-13 · 3y expired
What this patent protects
本发明公开了式(I)的氮杂环化合物、包含其的药物组合物及其制备方法和用途,具体而言,其用于预防或治疗与RET活性相关的疾病或病况的用途。
USPTO Abstract
本发明公开了式(I)的氮杂环化合物、包含其的药物组合物及其制备方法和用途,具体而言,其用于预防或治疗与RET活性相关的疾病或病况的用途。
Drugs covered by this patent
- Gavreto (PRALSETINIB) · Rigel Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.